BradleyMichaelHaverkosMD

PubMed

• Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy.
  Meryl Colton, Enkhtsetseg Purev, Bradley Haverkos, Steven Bair, Jagar Jasem
  Clinical Lymphoma, Myeloma & Leukemia. 2024-11-01
• High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.
  Narendranath Epperla, Adam S Zayac, Daniel J Landsburg, Allison M Bock, Grzegorz S Nowakowski
  Blood Advances. 2024-10-22
• DA-R-EPOCH May Mitigate the Adverse Prognostic Implication of the Diagnosis-to-Treatment Interval (DTI) in Large B-Cell Lymphomas.
  Jessica Allen, Diana Abbott, Joy Eskandar, Steven M Bair, Bradley Haverkos
  Clinical Lymphoma, Myeloma & Leukemia. 2024-09-26

Journal Articles

• Epstein-Barr Virus Type-2 Infects T-cells and Induces B-cell Lymphomagenesis in Humanized Mice  
  Bradley Haverkos, Zenggang Pan, mBio
• Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas  
  Haverkos, B., Huang, Y., Gru, A., Pancholi, P., Freud, A., Mishra, A., Ruppert, A., Baiocchi, R., & Porcu, P., IJC, 1/1/2017
• A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation  
  Haverkos, B. Huang, Y., Elder, P., O’Donnell, L., Scholl, D., Whittaker, B., Vasu, S., Penza, S., Andrtisos, L., Devine, S., & Jaglowski, S., BMT, 1/1/2017
• PD-1 Blockade in Mediastinal Gray-Zone Lymphoma  
  Melani C, Major A, Schowinsky J, Roschewski M, Pittaluga S, Jaffe ES, Pack SD, Abdullaev Z, Ahlman MA, Kwak JJ, Morgan R, Rabinovitch R, Pan Z, Haverkos BM, Gutman JA,..., NEJM, 1/1/2017
• Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL)  
  Haverkos, B., Coleman, C., Gru, A., Pan, Z., Brammer, J., Rochford, R., Mishra, A., Oakes, C., Baiocchi, R., Freud, A., & Porcu, P., Discovery Medicine, 1/1/2017
• Elevated plasma levels of Epstein Barr Virus DNA identify a poor-risk subset of patients with advanced stage cutaneous T-cell lymphoma  
  Haverkos, B., Gru, A., Geyer, S., Bingman, A., Hemminger, J., Mishra, A., Wong, H., Pancholi, P., Freud, A., Caligiuri, M., Baiocchi, R., Porcu, P., Clinical Lymphoma, Myeloma, & Leukemia, 1/1/2016
• Systemic therapy for cutaneous T-cell lymphoma: who, when, and why?  
  Virmani, P., Hwang, S., Hastings, J., Haverkos, B., Kohnken, B., Gru, A., Mishra, A., Fabbro, S., Horwitz, S., & Porcu, P., Expert Rev Heamtol, 1/1/2016
• Remission of an extensively pre-treated relapsing/refractory ALK-positive anaplastic large cell lymphoma following metronomic therapy  
  Yuan, S., Yu, J, Haverkos, B, & Su, H., Leuk Lymphoma, 1/1/2016
• Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases  
  Haverkos, B., Pan, Z., Gru, A., Freud, A., Rabinovitch, R., Xu-Welliver, M., Otto, B., Barrionueovo, C., Baiocchi, R., Rochford, R., & Porcu, P., Curr Hematol Malig Rep, 1/1/2016
• The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment  
  Haverkos BH, Gru AA, Freud AG, Hastings J, Nowacki NB, Barrionuevo C, Vigil CE, Rochford R, Natkunam Y, Baiocchi RA, et al, Curr Hematol Malig Rep, 1/8/2015
• The role of an integrated multidisciplinary clinic in the management of patients with cutaneous lymphoma  
  Haverkos, B., Tyler, K., Hu, Eileen, Philip, R., Gru, A., Welliver, M., Mishra, A., Wong, H., & Porcu, P., Frontiers Oncol, 1/1/2015
• Tocilizumab in the Treatment of Steroid Refractory Graft Versus Host Disease: A Single Institutional Experience  
  Roddy, J., Haverkos, B., McBride, A., Leininger, K., Andritsos, L., & Devine, S., Leukemia & Lymphoma, 1/1/2015
• Presentation, management, and experience in treating primary cutaneous B-cell lymphoma in the Multimodality Cutaneous Lymphoma Clinic at the Ohio State University  
  Haverkos, B., Tyler, K., Kartono, F., Frederickson, J., Elkins, C., Peters, S., Zhang, X., Wong, H., & Porcu, P., Oncologist, 1/1/2015
• Extranodal Marginal Zone Lymphoma (MALT) - Like Presentations of Angioimmunoblastic T-cell lymphoma: A T-cell lymphoma masquerading as a B-cell lymphoproliferative dis...  
  Kaffenberger, B., Haverkos, B., Tyler, K., Porcu, P., Wong, H., & Gru, A., American Journal of Dermatopathology, 1/1/2014
• Join now to see all

Abstracts/Posters

• Dose Reduction or Omission of Vinca Alkaloids during Initial Chemotherapy Treatment Does Not Impact Outcomes in Patients with Lymphoma
  Brad M. Haverkos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refracto...
  Brad M. Haverkos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Final Results of Phase 1/1b Study of Tenalisib, Dual PI3K _/_ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
  Brad M. Haverkos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Brad M. Haverkos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase 1 Trial Evaluating MRG-106, an Inhibitor of microRNA-155, Administered By Intratumoral, Subcutaneous, or Intravenous Delivery in Patients with Cutaneous T-cell L...
  Querfeld, C., Foss, F., Porcu, P., Kim, Y., Pacheco, T., Haverkos, B., Halwani, A., DeSimone, J., William, B., Seto, A., Ruckman, J., Landry, M., Jackson, A., Pestano,..., Lugano; ASH, 1/1/2017
• Oki, Y., Zain, J., Haverkos, B., Barde, P., Penmetsa, K., & Huen, A., Lugano; ASH, 1/1/2017
• A Phase I/II Trial of CHOEP Chemotherapy Plus Lenalidomide as Front Line Therapy for Patients with Stage II, III, and IV Peripheral T-cell Lymphoma: Phase 1 Results.
  Lunning, M., Horwitz, S., Mehta-Shah, N., Advani, R., Beaven, A., Haverkos, B., Lechowicz, M., Oki, Y., Zain, J., Ansell, S., Lugano, 1/1/2017
• Primary CNS Lymphoma.
  Haverkos, B., Internal Medicine Residency Program Education Sessions, 1/8/2016
• Severe acute graft versus host disease may complicate use of checkpoint blockade after allogeneic stem cell transplant in patients with classical Hodgkin lymphoma.
  Haverkos, B., Schowinsky, J., Kamdar, M. Andritsos, L., Gutman, J., & Devine, S., ASH Lymphoma Biology, Colorado Springs, CO, 1/1/2016
• Elevated plasma Epstein-Barr virus DNA predicts a poor prognosis in peripheral T-cell lymphomas.
  Haverkos, B., Huang, Y., Gru, A., Baiocchi, R., & Porcu, P., Society of Hematology Oncology, Houston, TX, 1/1/2015
• Prognostic value and latency analysis of serum Epstein-Barr Virus (EBV) DNA in advanced stage cutaneous T-cell lymphoma (CTCL).
  Haverkos, B., Hemminger, J., Geyer, S., Bingman, A., Wong, H., Gru, A., Ambinder, R., Baiocchi, R., & Porcu, T cell forum, 1/1/2014
• Prognostic implications, predictive value, and latency analysis of Epstein-Barr virus (EBV) DNA in advanced stage cutaneous T-cell lymphoma (AS-CTCL).
  Haverkos, B., Hemminger, J., Geyer, S., Bingman, A., Wong, H., Gru, A., Ambinder, R., Baiocchi, R., & Porcu, P., Journal of Clinical Oncology (Meeting Abstracts), 1/1/2014
• Mobilization for Autologous Stem Cell Transplantation in Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma: A single institution experience.
  Haverkos, B., Geyer, S., McBride, A., Penza, S., Devine, S., Andritsos, L., & Jaglowski, S., BMT Tandem Meeting, 1/1/2014
• A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients w...
  Haverkos, B., Cortright, K. Andritsos, L., Blum, W., Klisovic, R., Vasu, S., Devine, S., & Jaglowski, S, ASH, 1/1/2014
• Epstein-Barr Virus Kinase-Targeted Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder.
  Dugan, J., Haverkos, B., Martin, K., Martin, M., Patton, J., Lustberg, M., Nuovo, G., Yan, F., Cavaliere, R. Kenney, S., Fingeroth, J., Lozanski, G., Ramos, J., Porcu,..., ASH, 1/1/2014
• Tocilizumab in the Treatment of Steroid Refractory Graft Versus Host Disease: A Single Institutional Experience.
  Roddy, J., Haverkos, B., McBride, A., Leininger, K., Andritsos, L., & Devine, S., Blood; ASH annual meeting and exposition, New Orleans, LA, 1/15/2013
• Oncologic Services and Cancer Mortality in Chicago: An Analysis from 1995 to 2004.
  Haverkos, B., Hu, X., & Freeman, V., Minority Health in the Midwest conference, Chicago, IL, 1/24/2012
• Benefit Design of Medicare Drug Plans: An analysis of Ohio and the national landscape from 2006 through 2009.
  Haverkos, B., ACP conference, Chicago, IL, 1/1/2010
• The effect of theta-triggered trial presentation on learning-related hippocampal activity in rabbits (oryctolagus cuniculus). Department of Psychology and Center for N...
  Griffin, A., Vesco, R. Haverkos, B. & Berry S., Society of Neuroscience conference, Orlando, FL, 1/1/2002
• Join now to see all

Lectures

• CNS Lymphoma 
  1/28/2017
• Cutaneous Lymphomas 
  University of Colorado - 1/24/2017
• Aggressive Non-Hodgkin Lymphoma. 
  1/13/2017
• Non-cutaneous mature T and NK-cell Lymphoproliferative Disorders 
  University of Colorado - 1/10/2017
• Aggressive Lymphoma Review - For patients and caregivers. 
  1/8/2017
• Lymphoma Review – For healthcare professionals. 
  1/8/2017
• Cutaneous T-cell Lymphoma 
  1/5/2017
• Peripheral T-cell Lymphoma 
  1/5/2017
• CNS Lymphomas: Past, Present, and Future. 
  University of Colorado - 1/2/2017
• T and NK-Cell Lymphomas: Updates on Treatment. 
  1/13/2016
• T-cell lymphoma. 
  University of Colorado - 1/1/2016
• Elevated plasma Epstein-Barr virus DNA at diagnosis is a prognostic biomarker in peripheral T-cell lymphomas (PTCL). 
  Whistler, British Columbia, Canada - 1/1/2016
• Checkpoint Blockade For Treatment Of Lymphoma Following Allogeneic Stem Cell Transplant: Use May Be Complicated By Onset Of Severe Acute Graft Versus Host Disease. 
  1/1/2016
• ASH Review on T-cell lymphomas and bone marrow transplantation 
  University of Colorado - 1/18/2015
• Elevated plasma Epstein-Barr virus DNA predicts a poor prognosis in peripheral T-cell lymphomas. 
  Whistler, British Columbia, Canada - 1/1/2015
• Join now to see all

Other

• Benefit Design of Medicare Drug Plans: An Analysis of Ohio and the National Landscape from 2006 through 2009. 
  Haverkos, B., Part of Community Health and Preventative Medicine Commons
  http://corescholar.libraries.wright.edu/mph/20
  1/1/2009
• Langerhans Cell Histiocytosis. 
  Haverkos, B. & Light, D., Medpix Medical Image Database. Atlas, and Teaching File (electronic)
  http://rad.usuhs.edu/medpix/tf_case.html?mode=tf_case&pt_id=11573
  1/1/2007